Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07640490Phase 1Completed
Phase 1, randomised, double-blind trial in anxiety disorder and major depressive disorder (MDD) (2 arms), sponsored by Henan Provincial People's Hospital. Primary endpoints: Anxiety scale scores at 2 months and Depression scale scores at 2 months. Started Aug 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07640490.